The safety of a swine flu vaccine is to be investigated by European drugs regulators (EMEA, the European Medicines Agency) after it was linked to a rare condition that causes people to fall asleep suddenly.
The investigation has been prompted after health officials in Finland announced they were suspending the vaccination programme there following reports of narcolepsy in people who had received the jab.
So far there have been 27 reports of suspected narcolepsy in people across Europe who had previously been vaccinated with Pandemrix, the H1N1 swine flu vaccine made by GlaxoSmithKline.
Friday, August 27, 2010
From the Telegraph:
Posted by Meryl Nass, M.D. at 6:25 PM